Literature DB >> 17074970

Previously irradiated areas spared from skin toxicity induced by cetuximab in six patients: implications for the administration of EGFR inhibitors in previously irradiated patients.

P Bossi, C Liberatoscioli, C Bergamini, L D Locati, S Fava, G Rinaldi, E Orlandi, P Olmi, E Tagliabue, S Ménard, L Licitra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17074970     DOI： 10.1093/annonc/mdl409

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  7 in total

1.  Lack of Cetuximab induced skin toxicity in a previously irradiated field: case report and review of the literature.

Authors:  Madhava R Kanakamedala; Satyaseelan Packianathan; Srinivasan Vijayakumar
Journal:  Radiat Oncol       Date:  2010-05-17       Impact factor: 3.481

2.  Use of cetuximab in combination with pulsed reduced dose-rate radiotherapy in a patient with recurrence of nasopharyngeal carcinoma in the neck.

Authors:  Guang-Hui Li; Bo Zhu; Fan Yang; Chuan-Kun Ma; Ding-Qiang Yang
Journal:  Exp Ther Med       Date:  2012-03-05       Impact factor: 2.447

Review 3.  Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors.

Authors:  L Peuvrel; C Bachmeyer; Z Reguiai; J B Bachet; T André; R J Bensadoun; O Bouché; M Ychou; B Dréno
Journal:  Support Care Cancer       Date:  2012-02-24       Impact factor: 3.359

Review 4.  Mechanisms underlying skin disorders induced by EGFR inhibitors.

Authors:  Martin Holcmann; Maria Sibilia
Journal:  Mol Cell Oncol       Date:  2015-06-01

5.  IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes.

Authors:  Takashi K Satoh; Mark Mellett; Barbara Meier-Schiesser; Gabriele Fenini; Atsushi Otsuka; Hans-Dietmar Beer; Tamara Rordorf; Julia-Tatjana Maul; Jürg Hafner; Alexander A Navarini; Emmanuel Contassot; Lars E French
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

6.  A Novel Anti-EGFR mAb Ame55 with Lower Toxicity and Better Efficacy than Cetuximab When Combined with Irinotecan.

Authors:  Weiyi Qiu; Chang Zhang; Shuang Wang; Xiaoyan Yu; Qiong Wang; Dadi Zeng; Peng Du; Jinling Ma; Yiqiong Zheng; Bo Pang; Yunzhou Yu; Feng Long; Xiaobin Pang; Zhiwei Sun
Journal:  J Immunol Res       Date:  2019-01-13       Impact factor: 4.818

7.  Drug eruptions with novel targeted therapies - immune checkpoint and EGFR inhibitors.

Authors:  Isabella Pospischil; Wolfram Hoetzenecker
Journal:  J Dtsch Dermatol Ges       Date:  2021-11       Impact factor: 5.231
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.